REGN | Regeneron Pharmaceuticals
Category: Biotechnology company
Quick infos Headquarters: Tarrytown, New York, United States Trade prices Volume: 218K Market Cap: 74.21B Prev closed: 609.17 Open: 612.1 High: 630.76 Low: 608.76 52 week low: 271.37 52 week high: 646.33 Dividends: No Dividends Next ER: May 4, 2022 Before Market Opens
About the Company Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988.
Earnings History Date EPS / Forecast Revenue / Forecast August 4, 2022 May 4, 2022 11.49 / 9.722.97B / 2.69BBeat! February 4, 2022 23.72 / 20.44.95B / 4.56BBeat! November 4, 2021 15.37 / 10.363.45B / 2.75BBeat! August 5, 2021 25.8 / 17.725.14B / 3.96BBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 27, 2022 692.80 685.72 693.81
680.00
558.69K 1.37% May 26, 2022 683.44 690.12 697.01
682.90
523.54K -1.08% May 25, 2022 690.88 689.00 699.63
684.70
561.91K 0.71% May 24, 2022 686.02 681.97 686.33
667.75
463.11K 0.60% May 23, 2022 681.91 671.61 686.32
668.50
589.87K 3.14% May 20, 2022 661.14 661.29 664.90
647.54
544.27K 0.61% May 19, 2022 657.15 660.35 660.62
650.82
607.72K -0.31% May 18, 2022 659.20 664.10 672.54
655.25
557.66K -1.25% May 17, 2022 667.56 661.87 670.96
651.81
566.35K 1.92% May 16, 2022 655.01 640.18 656.45
640.18
486.04K 1.47% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US75886F1075 CUSIP: 75886F107 Founded:1988 Employees:5,400 News
FDA Expands Approval of Dupixent® (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma finance.yahoo.com Nov 5, 2021 5:29 pm
10 Best Cancer Stocks To Buy Now finance.yahoo.com Nov 5, 2021 3:25 pm
U.S. to open Canada, Mexico borders for vaccinated visitors finance.yahoo.com Nov 5, 2021 2:32 pm Top John Hancock Fund Bets Just On Its Best Ideas investors.com Nov 5, 2021 2:24 pm
NIH Director on FDA being careful in clearing Moderna vaccine for kids 12-17 finance.yahoo.com Nov 5, 2021 2:14 pm
3 Reasons Why Growth Investors Shouldn't Overlook Regeneron (REGN) finance.yahoo.com Nov 5, 2021 12:45 pm
Regeneron (REGN) Q3 Earnings Beat, REGEN-COV Boosts Growth finance.yahoo.com Nov 5, 2021 11:48 am
REGN or TECH: Which Is the Better Value Stock Right Now? finance.yahoo.com Nov 5, 2021 11:40 am 90,000 U.S. adult deaths from COVID-19 over the summer could have been prevented if victims had been vaccinated, study finds marketwatch.com Nov 5, 2021 10:51 am
Why Regeneron Shares Are Rising Today finance.yahoo.com Nov 5, 2021 10:28 am
Regeneron Earnings Blow Past Estimates on Strong Covid-19 Antibody Sales barrons.com Nov 5, 2021 9:53 am UPDATE 1-EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation finance.yahoo.com Nov 5, 2021 9:39 am
10 Healthcare Stocks to Buy According to Billionaire Noam Gottesmans GLG Partners finance.yahoo.com Nov 5, 2021 8:58 am Regeneron is seeking full FDA approval for its monoclonal antibody for two types of COVID-19 patients marketwatch.com Nov 5, 2021 7:50 am
Pfizer Stock Is Soaring Because Its Covid Antiviral Appears to Work Really, Really Well barrons.com Nov 5, 2021 7:38 am
Biotech Stock Roundup: BIIB's Q3 Earnings, REGN's COVID-19 Cocktail Update & More finance.yahoo.com Nov 5, 2021 11:38 am
Regeneron (REGN) Dupixent Meets Goal in Prurigo Nodularis Study finance.yahoo.com Nov 5, 2021 11:22 am
J&J (JNJ) Seeks Stelara Label Expansion in Juvenile Arthritis finance.yahoo.com Nov 5, 2021 11:11 am
Drug, Biotech Stock Q3 Earnings on Nov 4: MRNA, REGN & More finance.yahoo.com Nov 5, 2021 11:04 am
Bausch's (BHC) NOV03 for Dry Eye Disease Meets Study Goal finance.yahoo.com Nov 5, 2021 10:13 am This company doesn't provide a dividend.
Key Persons CEO : Leonard S. Schleifer, MD, PhD Talk about Regeneron Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
